PrimeVigilance, an Ergomed Group company, was established in 2008 by Dr. Miroslav Reljanovic together with co-founder Dr. Elliot Brown. PrimeVigilance offers holistic, top quality, cost-effective, innovative clinical safety and PV services for pharmaceutical, biotechnology and medical device companies. Our leaders have an unrivalled reputation in the sector with a network of SMEs across the world. These include former senior regulators and consultants with expansive industry experience.
We augment our domain expertise by integrating medical and scientific knowledge with regulatory science in clinical settings and in everyday practice. We identify previously unrecognized adverse effects or changes in their patterns to ascertain what action is necessary to optimize safe and effective use of medicines and medical devices. Our adaptable business models and integrative project management coupled with our flexibility as a partner, consistently fulfill our clients’ business requirements and safeguard their assets.
We bring together a team of 1000 professionals, located in 3 continents, whose skills, values and ingenuity make us unique in clinical safety and pharmacovigilance. We connect our clients to the right safety services and solutions. We specialize in helping emerging and established pharma and biotech companies comply with regulations, from developing PV systems right through to full management of safety operations. We are a partner who shares your commitment to patient safety and that purpose binds us all.
Industry
Biotechnology Research, Pharmaceutical Manufacturing
HQ Location
The Surrrey Research Park
1 Occam Court
Guildford, Surrey GU2 7HJ, GB
Keywords
PharmacovigilanceDrug SafetyClinical SafetyRegulatory ComplianceMedical Devices SafetyBiopharmaceuticalsRisk ManagementAdverse Event ReportingSignal DetectioSafety Data Management